Further characterization of the DCN-expressing tumor cells or stroma cell types, and cell-type-specific knockout of stromal DCN, may be crucial for fully demonstrating the roles of tumor cell or stroma-derived DCN in IBC tumor biology. This evidence concerns the gene DCN and inflammatory breast carcinoma.